Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

TUMOLO ANNETTE

2. Date of Event Requiring Statement (MM/DD/YYYY) 9/18/2017

3. Issuer Name and Ticker or Trading Symbol

BIO RAD LABORATORIES INC [BIO, BIOB]

(Last) (First) (Middle)

C/O BIO-RAD LABORATORIES, INC., 1000 ALFRED NOBEL DRIVE

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
Executive Vice President /

(Street)

HERCULES, CA 94547

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Bio-Rad A Common Stock	871.381	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Restricted Stock Units	⁽¹⁾	⁽¹⁾	Bio-Rad A Common Stock	400	$0 ⁽⁶⁾	D
Restricted Stock Units	⁽²⁾	⁽²⁾	Bio-Rad A Common Stock	800	$0 ⁽⁶⁾	D
Restricted Stock Units	⁽³⁾	⁽³⁾	Bio-Rad A Common Stock	1800	$0 ⁽⁶⁾	D
Restricted Stock Units	⁽⁴⁾	⁽⁴⁾	Bio-Rad A Common Stock	2400	$0 ⁽⁶⁾	D
Restricted Stock Units	⁽⁵⁾	⁽⁵⁾	Bio-Rad A Common Stock	3000	$0 ⁽⁶⁾	D
Non-Qualified Stock Option (right to buy)	⁽⁷⁾	9/7/2026	Bio-Rad A Common Stock	3000	$159.32	D
Non-Qualified Stock Option (right to buy)	⁽⁸⁾	9/5/2027	Bio-Rad A Common Stock	3000	$215.98	D

Explanation of Responses:
(1)	The restricted stock units vest in five equal annual installments beginning September 11, 2014.
(2)	The restricted stock units vest in five equal annual installments beginning September 10, 2015.
(3)	The restricted stock units vest in five equal annual installments beginning September 11, 2016.
(4)	The restricted stock units vest in five equal annual installments beginning September 7, 2017.
(5)	The restricted stock units vest in five equal annual installments beginning September 5, 2018.
(6)	Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
(7)	The options vest in five equal annual installments beginning September 7, 2017.
(8)	The options vest in five equal annual installments beginning September 5, 2018.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
TUMOLO ANNETTE C/O BIO-RAD LABORATORIES, INC. 1000 ALFRED NOBEL DRIVE HERCULES, CA 94547			Executive Vice President

Signatures
Annette Tumolo		9/26/2017
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.